Alerts will be sent to your verified email
Verify EmailAKUMS
Akums Drugs & Pharma
|
Procter&Gamble Healt
|
AMI Organics
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
DMF Filingsby API
|
20.0 . | n/a | n/a |
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
2.69 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
-1.49 % | 30.46 % | 18.21 % |
5yr average Equity Multiplier
|
3.89 | 2.99 | 1.75 |
5yr Average Asset Turnover Ratio
|
1.2 | 0.57 | 0.82 |
5yr Avg Net Profit Margin
|
0.42 % | 17.93 % | 12.12 % |
Price to Book
|
2.91 | 13.86 | 7.56 |
P/E
|
0.0 | 35.78 | 74.92 |
5yr Avg Cash Conversion Cycle
|
54.08 Days | -158.56 Days | 58.6 Days |
Inventory Days
|
59.02 Days | 36.98 Days | 65.78 Days |
Days Receivable
|
73.33 Days | 29.14 Days | 111.06 Days |
Days Payable
|
80.99 Days | 177.2 Days | 142.05 Days |
5yr Average Interest Coverage Ratio
|
5.39 | 337.3 | 19.71 |
5yr Avg ROCE
|
6.35 % | 19.93 % | 22.58 % |
5yr Avg Operating Profit Margin
|
5.28 % | 24.91 % | 19.73 % |
5 yr average Debt to Equity
|
0.47 | 0.0 | 0.34 |
5yr CAGR Net Profit
|
n/a | -4.58 % | 9.26 % |
5yr Average Return on Assets
|
0.52 % | 10.24 % | 10.12 % |
Shareholdings
|
|||
Promoter Holding
|
75.26 % | 51.82 % | 35.96 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -5.09 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.93 % | 4.1 % | 10.94 % |
Akums Drugs & Pharma
|
Procter&Gamble Healt
|
AMI Organics
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
Asset Break-Up - Segment Wise
|